- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07650279
Coherence Breathing Before Cardiopulmonary Exercise Testing
Acute Effects of Coherence Breathing on Cardiopulmonary Exercise Responses in Recreationally Active Adults: A Randomized Crossover Trial
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
Slow-paced breathing performed at approximately six breaths per minute has been shown to influence autonomic nervous system activity and heart rate variability. Coherence breathing may improve physiological regulation by enhancing cardiorespiratory synchronization and vagal modulation. However, little is known about whether a brief bout of coherence breathing performed immediately before exercise can influence cardiopulmonary exercise performance. The purpose of this study is to investigate the acute effects of pre-exercise coherence breathing on cardiopulmonary exercise performance and autonomic responses in recreationally active adults. This study will utilize a randomized, counterbalanced crossover design. Recreationally active adults aged 19 to 45 years will complete two experimental conditions in random order separated by a minimum of 48 hours (maximum of 7 days). In one condition, participants will perform 5 minutes of guided coherence breathing using a visual breathing pacer at approximately 6 breaths per minute while seated. In the comparison condition, participants will sit quietly for 5 minutes with spontaneous breathing. Following each condition, participants will complete a standardized treadmill warm-up and a maximal cardiopulmonary exercise test (CPET). Heart rate variability will be assessed during baseline seated rest and during the breathing intervention. Cardiopulmonary variables collected during CPET will include oxygen consumption, heart rate, respiratory responses, and ratings of perceived exertion. Recovery responses over 5 minutes seated include heart rate and blood pressure will also be assessed following exercise.
Findings from this study may improve our understanding of breathing strategies for athletic performance. Specifically, whether slow paced breathing through coherence breathing can serve as a practical autonomic priming strategy before maximal exercise. Moreover, insights from this study may provide insight into the acute interaction between breathing regulation, autonomic function, and exercise responses.
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Tamara Rial-Faigenbaum, PhD
- Número de telefone: 2159878984
- E-mail: trialfai@monmouth.edu
Estude backup de contato
- Nome: Jaime Pigman, PhD
- Número de telefone: 732-749-0160
- E-mail: jpigman@monmouth.edu
Locais de estudo
-
-
New Jersey
-
West Long Branch, New Jersey, Estados Unidos, 07764
- Monmouth University Graduate Center, Human Performance Lab, Room 222
-
Contato:
- Tamara Rial-Faigenbaum, PhD
- Número de telefone: 2159878984
- E-mail: trialfai@monmouth.edu
-
Contato:
- Jaime Pigman, PhD
- Número de telefone: 732-749-0160
- E-mail: jpigman@monmouth.edu
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
Aceita Voluntários Saudáveis
Descrição
Inclusion Criteria:
- Adults aged 19 to 45 years.
- Any biological sex.
- Recreationally active, defined as accumulating at least 3 hours per week of moderate-to-vigorous physical activity.
- Able to perform maximal cardiopulmonary exercise testing on a treadmill.
- Able to provide informed consent.
- Cleared for moderate-to-vigorous physical activity based on the PAR-Q+ (or PAR-Q 2023).
Exclusion Criteria:
- Accumulate less than 3 hours per week of moderate-to-vigorous physical activity.
- Presence of a health condition that contraindicates maximal exercise testing, including:
Cardiovascular disease. Pulmonary disease. Metabolic disorders. Neuromuscular disorders. Orthopedic limitations that impair exercise performance.
- Acute illness that would interfere with participation or exercise testing.
- Inability or unwillingness to complete study procedures.
- Inability or unwillingness to provide informed consent.
- Not cleared for moderate-to-vigorous physical activity based on the PAR-Q+ (or PAR-Q+ 2023).
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Outro
- Alocação: Randomizado
- Modelo Intervencional: Atribuição cruzada
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Coherence Breathing
Participants complete 5 minutes of guided coherence breathing
|
Participants complete 5 minutes of guided coherence breathing which consists or around 6 breathing cycles (5 seconds inhale and 5 seconds exhale)
Outros nomes:
|
|
Comparador Ativo: Spontaneous Breathing
Participants sit quietly for 5 minutes with spontaneous breathing
|
Participants sit quietly for 5 minutes with their regular spontaneous breathing
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Peak Oxygen consumption
Prazo: during each maximal exercise test immediately after the breathing condition
|
Peak oxygen consumption measured during the maximal cardiopulmonary exercise test (CPET) using a portable metabolic analyzer (Vo2 Master)
|
during each maximal exercise test immediately after the breathing condition
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
rating of perceived exertion (RPE)
Prazo: measured at baseline, during the exercise test and after recovery
|
using the RPE borg scale (from 1-10)
|
measured at baseline, during the exercise test and after recovery
|
|
Heart Rate Recovery
Prazo: difference between peak HR during CPET and HR at minute 1, minute 2 and minute 5 of recovery.
|
Heart Rate (bpm) immediately after completing the CPET over a period of 5 minutes
|
difference between peak HR during CPET and HR at minute 1, minute 2 and minute 5 of recovery.
|
|
Time to completion of maximal exercise test
Prazo: during the exercise test
|
total duration of the exercise test since test starts to voluntary termination
|
during the exercise test
|
|
Peak Heart Rate
Prazo: measured during the maximal exercise test
|
maximal heart rate achieved during the maximal exercise test
|
measured during the maximal exercise test
|
Colaboradores e Investigadores
Patrocinador
Publicações e links úteis
Publicações Gerais
- Laborde S, Allen MS, Borges U, Dosseville F, Hosang TJ, Iskra M, Mosley E, Salvotti C, Spolverato L, Zammit N, Javelle F. Effects of voluntary slow breathing on heart rate and heart rate variability: A systematic review and a meta-analysis. Neurosci Biobehav Rev. 2022 Jul;138:104711. doi: 10.1016/j.neubiorev.2022.104711. Epub 2022 May 24.
- Sevoz-Couche C, Laborde S. Heart rate variability and slow-paced breathing:when coherence meets resonance. Neurosci Biobehav Rev. 2022 Apr;135:104576. doi: 10.1016/j.neubiorev.2022.104576. Epub 2022 Feb 12.
- Trinkunas E, Kairiukstiene Z, Trinkunaite M, Poderiene K, Brazdzionyte R, Poderys J. Post-Exercise Controlled Breathing Enhances Cardiovascular Recovery and Autonomic Balance: A Randomised Crossover Study. Medicina (Kaunas). 2026 Feb 3;62(2):318. doi: 10.3390/medicina62020318.
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- SP2645
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .